UMEDICA is a part of the Amoli Group of Companies, manufacturing and exporting a wide range of formulations viz; Injectables, Tablets, Capsules, Suspensions, Dry Syrups, etc. UMEDICA offers a diverse product portfolio with a patient-centric approach comprising of antibiotics, anti-diabetics, anti-hyperlipidemic, anti-hypertensives, non-steroidal anti-inflammatory (NSAIDs), analgesics, antifungal, anti-malarial, antihistaminics, psychotropic, diuretics, anti-hypertensives, drugs for sexual dysfunction and multivitamins etc.

We at UMEDICA strive to achieve more through a culture of innovation & continuous improvement.

UMEDICA's manufacturing facility, located in Vapi, Gujarat is a WHO GMP approved, US FDA, EU, Health Canada, TGA & UAE MoH approved facility. The facility has also been audited and approved by Regulatory authorities of various countries viz. USA, EU, Australia, Canada, UAE, Zimbabwe, Ethiopia, Tanzania, Nigeria, Uganda, Kenya, Ghana, Ivory Coast, Malawi etc.

The manufacturing capabilities of UMEDICA are supported by a full-fledged R&D Centre manned by well qualified and experienced team of scientists to improve on the existing products and develop new formulations.

UMEDICA is backed by a highly skilled team of regulatory affairs specialists who are well versed with international regulatory policies and procedures.

UMEDICA has business operations in more than 85 countries covering US, EU, Canada, Australia, Middle East, Central & South American countries, Africa, Asian & CIS countries.

UMEDICA is a Government recognized Export House that has been awarded ‘Chemexcil’ Top Export Award for performance in exports.

Associate Companies